Header Logo

Connection

Cheryl Cohen to Middle Aged

This is a "connection" page, showing publications Cheryl Cohen has written about Middle Aged.
Connection Strength

3,559
  1. Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
    View in: PubMed
    Score: 0,134
  2. Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 - 2018. BMC Infect Dis. 2024 Oct 09; 24(1):1128.
    View in: PubMed
    Score: 0,133
  3. Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa. Int J Epidemiol. 2024 Aug 14; 53(5).
    View in: PubMed
    Score: 0,131
  4. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet. 2022 01 29; 399(10323):437-446.
    View in: PubMed
    Score: 0,110
  5. Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017-18 (PHIRST): a population cohort study. Lancet Glob Health. 2021 06; 9(6):e863-e874.
    View in: PubMed
    Score: 0,105
  6. A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme. Vaccine. 2021 01 08; 39(2):412-422.
    View in: PubMed
    Score: 0,102
  7. Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 10 21; 38(45):7007-7014.
    View in: PubMed
    Score: 0,100
  8. Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 06 02; 38(27):4288-4297.
    View in: PubMed
    Score: 0,098
  9. Household Transmission of Seasonal Influenza From HIV-Infected and HIV-Uninfected Individuals in South Africa, 2013-2014. J Infect Dis. 2019 04 19; 219(10):1605-1615.
    View in: PubMed
    Score: 0,091
  10. Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa. Vaccine. 2019 01 03; 37(1):25-33.
    View in: PubMed
    Score: 0,088
  11. Responses to hypothetical health scenarios overestimate healthcare utilization for common infectious syndromes: a cross-sectional survey, South Africa, 2012. BMC Infect Dis. 2018 07 25; 18(1):344.
    View in: PubMed
    Score: 0,086
  12. The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013-2015. Influenza Other Respir Viruses. 2018 05; 12(3):360-373.
    View in: PubMed
    Score: 0,083
  13. In- and Out-of-hospital Mortality Associated with Seasonal and Pandemic Influenza and Respiratory Syncytial Virus in South Africa, 2009-2013. Clin Infect Dis. 2018 01 06; 66(1):95-103.
    View in: PubMed
    Score: 0,083
  14. Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016. Emerg Infect Dis. 2017 07; 23(7):1124-1132.
    View in: PubMed
    Score: 0,080
  15. Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015. Influenza Other Respir Viruses. 2017 03; 11(2):177-181.
    View in: PubMed
    Score: 0,077
  16. Knowledge, attitudes, and practices about influenza illness and vaccination: a cross-sectional survey in two South African communities. Influenza Other Respir Viruses. 2016 09; 10(5):421-8.
    View in: PubMed
    Score: 0,074
  17. Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014. Influenza Other Respir Viruses. 2015 Jul; 9(4):209-15.
    View in: PubMed
    Score: 0,070
  18. Mortality Associated With Seasonal and Pandemic Influenza Among Pregnant and Nonpregnant Women of Childbearing Age in a High-HIV-Prevalence Setting-South Africa, 1999-2009. Clin Infect Dis. 2015 Oct 01; 61(7):1063-70.
    View in: PubMed
    Score: 0,069
  19. Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013. Influenza Other Respir Viruses. 2015 May; 9(3):143-50.
    View in: PubMed
    Score: 0,069
  20. Deaths associated with respiratory syncytial and influenza viruses among persons =5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis. 2015 Apr; 21(4):600-8.
    View in: PubMed
    Score: 0,069
  21. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PLoS One. 2015; 10(3):e0118884.
    View in: PubMed
    Score: 0,068
  22. Epidemiology of severe acute respiratory illness (SARI) among adults and children aged =5 years in a high HIV-prevalence setting, 2009-2012. PLoS One. 2015; 10(2):e0117716.
    View in: PubMed
    Score: 0,068
  23. Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010-2011. BMC Infect Dis. 2015 Jan 27; 15:26.
    View in: PubMed
    Score: 0,068
  24. Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012. BMC Infect Dis. 2014 Dec 16; 14:694.
    View in: PubMed
    Score: 0,067
  25. Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis. 2014 Jul; 20(7):1162-9.
    View in: PubMed
    Score: 0,065
  26. Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009. PLoS One. 2014; 9(4):e94681.
    View in: PubMed
    Score: 0,064
  27. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013 Nov; 19(11):1766-74.
    View in: PubMed
    Score: 0,062
  28. Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America. Clin Infect Dis. 2012 Oct; 55(7):996-1003.
    View in: PubMed
    Score: 0,057
  29. Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin Infect Dis. 2005 Dec 01; 41(11):1631-7.
    View in: PubMed
    Score: 0,036
  30. Corynebacterium diphtheriae Infections, South Africa, 2015-2023. Emerg Infect Dis. 2025 Mar; 31(3):417-426.
    View in: PubMed
    Score: 0,034
  31. Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev Study. BMJ Open. 2024 12 20; 14(12):e080553.
    View in: PubMed
    Score: 0,034
  32. Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis. Lancet Infect Dis. 2025 Apr; 25(4):457-470.
    View in: PubMed
    Score: 0,034
  33. Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
    View in: PubMed
    Score: 0,033
  34. Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection. Nat Commun. 2024 Aug 22; 15(1):7240.
    View in: PubMed
    Score: 0,033
  35. Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study. J Infect. 2024 May; 88(5):106154.
    View in: PubMed
    Score: 0,032
  36. Optimal age targeting for pneumococcal vaccination in older adults; a modelling study. Nat Commun. 2023 02 16; 14(1):888.
    View in: PubMed
    Score: 0,030
  37. Unmasking Pneumococcal Carriage in a High Human Immunodeficiency Virus (HIV) Prevalence Population in two Community Cohorts in South Africa, 2016-2018: The PHIRST Study. Clin Infect Dis. 2023 02 08; 76(3):e710-e717.
    View in: PubMed
    Score: 0,030
  38. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. Lancet Glob Health. 2022 09; 10(9):e1247-e1256.
    View in: PubMed
    Score: 0,029
  39. Methods for early characterisation of the severity and dynamics of SARS-CoV-2 variants: a population-based time series analysis in South Africa. Lancet Microbe. 2022 10; 3(10):e753-e761.
    View in: PubMed
    Score: 0,029
  40. SARS-CoV-2 cases reported from long-term residential facilities (care homes) in South Africa: a retrospective cohort study. BMC Public Health. 2022 May 24; 22(1):1035.
    View in: PubMed
    Score: 0,028
  41. Estimating the contribution of HIV-infected adults to household pneumococcal transmission in South Africa, 2016-2018: A hidden Markov modelling study. PLoS Comput Biol. 2021 12; 17(12):e1009680.
    View in: PubMed
    Score: 0,027
  42. SARS-CoV-2 Seroprevalence in a Rural and Urban Household Cohort during First and Second Waves of Infections, South Africa, July 2020-March 2021. Emerg Infect Dis. 2021 12; 27(12):3020-3029.
    View in: PubMed
    Score: 0,027
  43. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Glob Health. 2021 09; 9(9):e1216-e1225.
    View in: PubMed
    Score: 0,026
  44. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis. PLoS Med. 2021 03; 18(3):e1003550.
    View in: PubMed
    Score: 0,026
  45. Human surveillance and phylogeny of highly pathogenic avian influenza A(H5N8) during an outbreak in poultry in South Africa, 2017. Influenza Other Respir Viruses. 2020 05; 14(3):266-273.
    View in: PubMed
    Score: 0,024
  46. Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. Euro Surveill. 2019 Nov; 24(45).
    View in: PubMed
    Score: 0,024
  47. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016. Clin Infect Dis. 2019 07 18; 69(3):495-504.
    View in: PubMed
    Score: 0,023
  48. Healthcare seeking behaviour for common infectious syndromes among people in three administrative regions of Johannesburg, South Africa, 2015: a cross-sectional study. Pan Afr Med J. 2019; 33:159.
    View in: PubMed
    Score: 0,023
  49. The Fraction of Rhinovirus Detections Attributable to Mild and Severe Respiratory Illness in a Setting of High Human Immunodeficiency Virus Prevalence, South Africa, 2013-2015. J Infect Dis. 2019 05 05; 219(11):1697-1704.
    View in: PubMed
    Score: 0,023
  50. Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014. J Infect Dis. 2018 09 08; 218(8):1228-1237.
    View in: PubMed
    Score: 0,022
  51. Healthcare utilization for common infectious disease syndromes in Soweto and Klerksdorp, South Africa. Pan Afr Med J. 2018; 30:271.
    View in: PubMed
    Score: 0,022
  52. Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014. BMC Infect Dis. 2018 06 08; 18(1):269.
    View in: PubMed
    Score: 0,021
  53. Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015. Emerg Infect Dis. 2018 03; 24(3):506-513.
    View in: PubMed
    Score: 0,021
  54. Invasive Disease Caused Simultaneously by Dual Serotypes of Streptococcus pneumoniae. J Clin Microbiol. 2018 01; 56(1).
    View in: PubMed
    Score: 0,021
  55. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018 03 31; 391(10127):1285-1300.
    View in: PubMed
    Score: 0,021
  56. Influenza-associated mortality in South Africa, 2009-2013: The importance of choices related to influenza infection proxies. Influenza Other Respir Viruses. 2018 01; 12(1):54-64.
    View in: PubMed
    Score: 0,021
  57. Enterovirus genotypes among patients with severe acute respiratory illness, influenza-like illness, and asymptomatic individuals in South Africa, 2012-2014. J Med Virol. 2017 10; 89(10):1759-1767.
    View in: PubMed
    Score: 0,020
  58. Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017 10; 75(4):346-355.
    View in: PubMed
    Score: 0,020
  59. Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014. PLoS One. 2017; 12(5):e0177655.
    View in: PubMed
    Score: 0,020
  60. Knowledge, attitudes and practices of South African healthcare workers regarding the prevention and treatment of influenza among HIV-infected individuals. PLoS One. 2017; 12(3):e0173983.
    View in: PubMed
    Score: 0,020
  61. Development of a respiratory severity score for hospitalized adults in a high HIV-prevalence setting-South Africa, 2010-2011. BMC Pulm Med. 2017 02 02; 17(1):28.
    View in: PubMed
    Score: 0,019
  62. Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study. Vaccine. 2016 11 04; 34(46):5649-5655.
    View in: PubMed
    Score: 0,019
  63. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One. 2016; 11(2):e0149104.
    View in: PubMed
    Score: 0,018
  64. Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013. Emerg Infect Dis. 2016 Feb; 22(2):261-70.
    View in: PubMed
    Score: 0,018
  65. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26; 15:450.
    View in: PubMed
    Score: 0,018
  66. Human metapneumovirus-associated severe acute respiratory illness hospitalisation in HIV-infected and HIV-uninfected South African children and adults. J Clin Virol. 2015 Aug; 69:125-32.
    View in: PubMed
    Score: 0,017
  67. Severe Acute Respiratory Illness Deaths in Sub-Saharan Africa and the Role of Influenza: A Case Series From 8 Countries. J Infect Dis. 2015 Sep 15; 212(6):853-60.
    View in: PubMed
    Score: 0,017
  68. Genetic diversity and molecular epidemiology of human rhinoviruses in South Africa. Influenza Other Respir Viruses. 2014 Sep; 8(5):567-73.
    View in: PubMed
    Score: 0,016
  69. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014 Nov 15; 210(10):1649-57.
    View in: PubMed
    Score: 0,016
  70. Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010. Antimicrob Agents Chemother. 2014 Jun; 58(6):3293-305.
    View in: PubMed
    Score: 0,016
  71. Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J Infect. 2014 May; 68(5):455-61.
    View in: PubMed
    Score: 0,016
  72. Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S227-37.
    View in: PubMed
    Score: 0,016
  73. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis. 2014 Jan 01; 209(1):56-65.
    View in: PubMed
    Score: 0,015
  74. Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S14-21.
    View in: PubMed
    Score: 0,015
  75. Introduction of 2009 pandemic influenza A virus subtype H1N1 into South Africa: clinical presentation, epidemiology, and transmissibility of the first 100 cases. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S148-53.
    View in: PubMed
    Score: 0,015
  76. Twenty-five years of outpatient influenza surveillance in South Africa, 1984-2008. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S153-8.
    View in: PubMed
    Score: 0,015
  77. Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S159-65.
    View in: PubMed
    Score: 0,015
  78. Systemic shigellosis in South Africa. Clin Infect Dis. 2012 May; 54(10):1448-54.
    View in: PubMed
    Score: 0,014
  79. Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease. Antimicrob Agents Chemother. 2012 Mar; 56(3):1602-5.
    View in: PubMed
    Score: 0,014
  80. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program. PLoS One. 2011; 6(11):e27929.
    View in: PubMed
    Score: 0,014
  81. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety. Clin Infect Dis. 2011 Jan 01; 52(1):128-37.
    View in: PubMed
    Score: 0,013
  82. Nosocomial outbreak of novel arenavirus infection, southern Africa. Emerg Infect Dis. 2009 Oct; 15(10):1598-602.
    View in: PubMed
    Score: 0,012
  83. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis. 2008 Feb 01; 46(3):377-86.
    View in: PubMed
    Score: 0,010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.